Treatment
Reference Drug clinical trials
We’re tracking 7 recruiting studies that include Reference Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06599528RecruitingPhase 1
Comparing a new hormone injection to Ovidrel in healthy women
This study compares a new injected hormone (SJ04) with a standard one (Ovidrel) to see if they work similarly. It's for healthy women with regular cycles who might need help with fertility treatments.
Suzhou, JiangsuAges 20–40 - NCT07643220RecruitingPhase 1
Comparing Two Versions of a Hair-Loss Medication
This study tests whether two versions of the same medication (AJU-G721 and G721R)—used to treat hair loss and urinary symptoms—work the same way in the body. Researchers will measure how much medication gets absorbed and how long it stays in your system.
SeoulAges 19–54 - NCT06834100RecruitingPhase 3
Comparing a new meningitis vaccine to an approved one
This trial tests a new meningitis vaccine (GNG-DE) to see how well it works compared to a vaccine already on the market. It might help protect you or your child from meningococcal disease.
KirovAges 3–55 - NCT07708142RecruitingPhase 3
Testing a new injection for swelling after retinal vein blockage
This trial tests a new medicine called SMO1 for people with vision loss and swelling in the eye caused by a blocked vein in the retina. It involves regular eye injections to see if the medicine can reduce swelling and improve vision.
Seoul, Gangdong-guAges 19 years+ - NCT07156916RecruitingPhase 1
Tamsulosin tablet comparison study in healthy men
This trial tests how a new tamsulosin tablet (used for prostate problems) compares to the standard drug in healthy men. You will take one dose and have blood samples taken to measure the drug levels.
Yerevan, Ankuk RegionAges 18–45 - NCT06100510Enrolling by invitationPhase 4
Platelet function test in healthy adults
This trial is collecting blood from healthy adults to establish a new reference range for a standard platelet function test. You may be eligible if you do not have any bleeding disorders, are not taking blood thinners or anti-inflammatory medications, and meet other lab criteria.
East Syracuse, New YorkAges 18 years+ - NCT04300556RecruitingPhase 1/Phase 2
Testing an antibody-drug for advanced certain cancers
This early-phase trial tests a treatment called MORAb-202, an antibody “delivery” drug, to see if it’s safe and can help shrink or control certain advanced cancers. It may help people whose tumors match the study’s specific cancer types and prior treatment history.
Tucson, ArizonaAges 18 years+
What Reference Drug is being studied for
Conditions with recruiting Reference Drug studies.
Common questions
- Are there clinical trials studying Reference Drug?
- Yes. Clin2 currently lists 7 recruiting studies that include Reference Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Reference Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Reference Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Reference Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.